2802. Frequency, Antimicrobial Susceptibility, and Molecular Characterization of Carbapenem-Resistant Enterobacterales Stratified by United States Census Divisions: Results from the INFORM Program (2018-2022)

BACKGROUND: Recently approved β-lactamase inhibitor combinations (BLIs), such as ceftazidime-avibactam (CAZ-AVI) and meropenem-vaborbactam (MEM-VAB), have demonstrated a broad spectrum of activity against carbapenem-resistant Enterobacterales (CRE) from US hospitals, but resistance may emerge with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Kimbrough, John H, Doyle, Timothy, Carvalhaes, Cecilia G, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678679/
http://dx.doi.org/10.1093/ofid/ofad500.2413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678679/
http://dx.doi.org/10.1093/ofid/ofad500.2413

Ejemplares similares